HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Pablo Barreiro Selected Research

Antiviral Agents (Antivirals)

3/2015Drug interactions with new hepatitis C oral drugs.
1/2015Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.
1/2014Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies.
9/2013Update on HIV/HCV coinfection.
2/2013Hepatitis C therapy: highlights from the 2012 annual meeting of the European Association for the Study of the Liver.
1/2013The changing face of hepatitis C in the new era of direct-acting antivirals.
1/2013Pharmacokinetics of new oral hepatitis C antiviral drugs.
1/2013The changing epidemiology of liver disease in HIV patients.
2/2012Treatment failure with new hepatitis C drugs.
8/2011Directly acting antivirals against hepatitis C virus.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Pablo Barreiro Research Topics

Disease

33Chronic Hepatitis C
10/2015 - 05/2003
28Infection
09/2015 - 02/2004
23Hepatitis C
01/2015 - 01/2005
21Liver Cirrhosis (Hepatic Cirrhosis)
10/2015 - 04/2006
13HIV Infections (HIV Infection)
03/2015 - 10/2002
13Fibrosis (Cirrhosis)
01/2015 - 12/2004
11Liver Diseases (Liver Disease)
05/2014 - 12/2004
8Viremia
10/2015 - 07/2003
8Chronic Hepatitis B
09/2013 - 04/2007
5Hepatitis B
09/2015 - 10/2002
4Acquired Immunodeficiency Syndrome (AIDS)
09/2015 - 06/2008
4Anemia
12/2011 - 08/2005
3End Stage Liver Disease
03/2010 - 09/2006
3Hyperbilirubinemia
11/2008 - 01/2006
3Pancreatitis
09/2006 - 05/2003
2Neoplasms (Cancer)
09/2015 - 03/2015
2Hepatitis D
10/2014 - 11/2011
2Hepatitis
05/2013 - 01/2010
2Inflammation
05/2013 - 01/2009
2Portal Hypertension
05/2010 - 11/2008
2Cardiovascular Diseases (Cardiovascular Disease)
07/2009 - 10/2002
2Insulin Resistance
06/2008 - 04/2008
2Lipodystrophy
07/2005 - 10/2002
1Chronic Disease (Chronic Diseases)
03/2015
1Alcoholism (Alcohol Abuse)
01/2014
1Chronic Hepatitis (Chronic Active Hepatitis)
08/2013
1Mental Disorders (Mental Disorder)
04/2012
1Hemolytic Anemia
04/2010
1Familial Hypophosphatemia (Phosphate Diabetes)
03/2009
1Autoimmune Hepatitis
12/2008
1Jaundice
11/2008
1Hemolysis
11/2008
1Hemorrhage
11/2008
1Dyslipidemias (Dyslipidemia)
04/2008
1Fatty Liver
04/2008
1Hyperplasia
01/2008

Drug/Important Bio-Agent (IBA)

29Ribavirin (Virazole)FDA LinkGeneric
01/2015 - 05/2003
26InterferonsIBA
01/2015 - 08/2004
21RNA (Ribonucleic Acid)IBA
10/2015 - 05/2003
12Carbon MonoxideIBA
09/2015 - 10/2002
12Antiviral Agents (Antivirals)IBA
03/2015 - 05/2008
9tenofovirFDA Link
02/2015 - 04/2006
6Didanosine (Videx)FDA LinkGeneric
05/2010 - 05/2003
5DNA (Deoxyribonucleic Acid)IBA
02/2015 - 03/2007
5Protease Inhibitors (Protease Inhibitor)IBA
01/2015 - 10/2002
4Lamivudine (3TC)FDA Link
02/2015 - 10/2007
4Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2014 - 09/2006
4atazanavir (Reyataz)FDA Link
07/2009 - 01/2006
3Alanine Transaminase (SGPT)IBA
05/2013 - 04/2006
3TransaminasesIBA
01/2008 - 06/2006
3efavirenz (Sustiva)FDA Link
10/2007 - 07/2003
2InterleukinsIBA
11/2013 - 03/2012
2Hepatitis B e AntigensIBA
09/2013 - 04/2007
2N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
01/2013 - 09/2012
2telaprevirIBA
01/2013 - 09/2012
2inosine triphosphataseIBA
03/2012 - 12/2011
2Glucose (Dextrose)FDA LinkGeneric
01/2010 - 10/2002
2Interferon-alpha (Interferon Alfa)FDA Link
05/2008 - 08/2005
2Nevirapine (Viramune)FDA Link
04/2008 - 07/2003
2Zidovudine (Retrovir)FDA LinkGeneric
09/2006 - 03/2006
1VaccinesIBA
09/2015
1P-GlycoproteinIBA
03/2015
1lipoarabinomannan (LAM)IBA
02/2015
1HIV Protease InhibitorsIBA
01/2015
1Viral RNAIBA
10/2013
1AntibodiesIBA
07/2013
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
05/2013
1Interleukin-10 (Interleukin 10)IBA
05/2013
1Biological Markers (Surrogate Marker)IBA
05/2013
1Triglycerides (Triacylglycerol)IBA
05/2013
1Non-alcoholic Fatty Liver DiseaseIBA
01/2013
1Psychotropic Drugs (Psychoactive Drugs)IBA
04/2012
1LDL CholesterolIBA
03/2012
1DEBIO-025IBA
08/2011
1Hemoglobins (Hemoglobin)IBA
04/2010
1ErythropoietinFDA Link
04/2010
1tenofovir disoproxil (Viread)FDA Link
01/2010
1Insulin (Novolin)FDA Link
01/2010
1darunavir (Prezista)FDA Link
07/2009
1tipranavirFDA Link
07/2009
1TruvadaFDA Link
03/2009
1F 4 (F-4)IBA
12/2008
1Anti-Retroviral Agents (Antiretroviral Agents)IBA
06/2008
1adefovirIBA
05/2008
1entecavirFDA Link
05/2008
1emtricitabine (Emtriva)FDA Link
05/2008
1telbivudineFDA Link
05/2008
1Serine Proteases (Serine Protease)IBA
03/2008
1DNA-Directed RNA Polymerases (RNA Polymerase)IBA
03/2008
1abacavir (Ziagen)FDA Link
01/2008
1peginterferon alfa-2a (Pegasys)FDA Link
08/2007
1AntigensIBA
04/2007
1Reverse Transcriptase InhibitorsIBA
04/2007
1Mitochondrial DNA (mtDNA)IBA
03/2007

Therapy/Procedure

12Highly Active Antiretroviral Therapy (HAART)
03/2015 - 10/2002
3Therapeutics
09/2013 - 08/2011
1Drug Therapy (Chemotherapy)
09/2015
1Art Therapy
05/2013
1Retreatment
03/2010
1Liver Transplantation
01/2010